Headquartered in Building 5, Watford Fiscal year ends December NYSE: SNN smith-nephew.com
Smith & Nephew plc is a portfolio medical technology business focused on the repair, regeneration, and replacement of soft and hard tissue. The company operates through three global business units: Orthopaedics (knee implants, hip implants, trauma & extremities, and other reconstruction including robotics-assisted surgery), Sports Medicine & ENT (joint repair, arthroscopic enabling technologies, and ear, nose and throat), and Advanced Wound Management (wound care dressings, bioactives including skin substitutes, and wound devices including negative pressure wound therapy). The company employs approximately 17,000 people, operates in around 100 countries, and generated annual sales of $6.2 billion in 2025. Key product platforms include the CORI Surgical System for robotics-assisted surgery, CATALYSTEM Primary Hip System, LEGION knee system, REGENETEN Bioinductive Implant, ALLEVYN wound care dressings, PICO single-use negative pressure wound therapy, and the recently FDA-cleared TESSA Spatial Surgery System utilizing AI and augmented reality for arthroscopic procedures. The company is executing its RISE strategy (Reach, Innovate, Scale, Execute) to accelerate growth and improve returns, supported by ongoing efficiency initiatives under a 12-Point Plan and zero-based budgeting program. Updated
The top analyst upgrades, downgrades and other research calls from Wednesday include AECOM, CyberArk, Dillard's, Hasbro, Mattel, Newell, Papa John's, Shopify, Snap and Tesla.
The top analyst upgrades, downgrades and other research calls from Wednesday include AbbVie, Gilead, Johnson & Johnson, Potash, Schlumberger, Visa and Walmart.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Eldorado Gold, SLM, SunPower, Disney, Yelp and Myriad Genetics.
The top analyst upgrades, downgrades and initiations seen on Monday morning include Altria, BB&T, Capital One, CenterPoint Energy, Occidental Petroleum, Vale and Workday.
Tuesday's top analyst upgrades, downgrades and initiations include Newmont Mining, Vodafone, Yelp, Western Digital, American Airlines and AT&T.
Here are four top medical device makers that the Leerink team thinks make sense as potential takeover candidates, but also have more than enough merit to stand on their own.
Jon OggStocks have pulled back over the past week, after eight straight weeks of rallying. Now investors are getting ready for year-end and positioning themselves for 2014. 24/7 Wall St. goes over…
These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Tuesday, August 13, 2013. They include Allot Communications, Microsoft, Vical and First Solar.
ThinkstockChinese for-profit education company Ambow Education Holding Ltd. (NYSE: AMBO) got some bad news earlier this week. A proposed buyout by private equity firm Barings Asia Private Equity Fund V L.P. was…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Friday morning. Arch Coal, Inc. (NYSE: ACI) named as Bear of the Day with…
There are many new characters in this week’s installment of “The Unusual Suspects for the Week Ahead.” We have tracked news and added color on each where applicable. The cast of characters…
Smith & Nephew plc (NYSE: SNN) is trading higher today on reports that it rebuffed an approach for a takeover by Johnson & Johnson (NYSE: JNJ). What is interesting about the implied…
These are some of this Friday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Canadian Pacific Railway (NYSE: CP) Cut to Market Perform at Raymond James. CME Group…
These are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls: Allied Irish Bank Group (NYSE: AIB) Cut to Hold and Target Cut to 1.02…
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research early this Wednesday. Some of the U.S. calls will get pretty thin as we get closer…
Smith & Nephew plc is a portfolio medical technology business focused on the repair, regeneration, and replacement of soft and hard tissue.
24/7 Wall St.'s 12-month price target for SNN is $22.31, rated Sell. The Wall Street consensus target is $32.72. SNN price prediction →
